Zealthy Reviews: Pricing, Lawsuit & Verdict

A compressed corporate history:

• December 2022: Kyle Robertson founds Zealthy after leaving Cerebral
• January 2023: Zealthy Inc. renamed to Gronk Inc.
• 2023-2024: Platform expands across 34 states, surpasses 100,000 patients
• June 2024: DOJ files ROSCA lawsuit against Zealthy, Robertson, and Echeverry
• February 2026: FDA issues warning letter to FitRx LLC for misbranded drugs
• March 2026: DOJ lawsuit still pending, no settlement reached

Sources: Zealthy website, ConsumerAffairs, DOJ complaint. Prices verified March 2026.

The total cost for compounded semaglutide is $286 per month ($135 membership + $151 medication). For compounded tirzepatide, the total is $351 per month ($135 + $216). These numbers are competitive with the rest of the market, though not the cheapest. Peak Wellness charges $129 per month for compounded semaglutide, and GobyMeds charges $119 per month.

The bundled option ($349 first month, then $449/month) is worth scrutiny. Unbundled semaglutide costs $286/month total. Unbundled tirzepatide costs $351/month total. The bundled plan costs roughly $100 more per month than buying membership and medication separately, with no clear added benefit.

For context on how these medications are dosed, see our semaglutide dosage chart and tirzepatide dosage chart.

The DOJ complaint filed in June 2024 specifically alleges that Zealthy advertised pricing of "$25 with insurance" and "$150 without insurance" but consumers paid "multiples more." The complaint claims Zealthy violated the Restore Online Shoppers' Confidence Act (ROSCA) by failing to disclose subscription terms clearly.

Five billing details to know before signing up:

• The $135 membership fee is separate from medication costs. Promotional landing pages advertising "$39 first month" or "$49 first month" refer to the membership only, not the medication.
• A 3-month commitment gives a 20% discount on the second and third months of membership (~$108/month).
• Multiple customers report charges under alternate names, including "ZFit," which creates confusion on bank statements.
• Cancellation reportedly continues to generate charges for some users. The DOJ complaint cites failures to provide "simple cancellation mechanisms."
• The initial health assessment ($39) may be charged separately from the first month's membership fee.

None of these are necessarily fraudulent, but the disclosure is not always clear at the point of purchase.

Zealthy offers compounded versions of four GLP-1 medications:

• Semaglutide (the active ingredient in Ozempic and Wegovy)
• Tirzepatide (the active ingredient in Mounjaro and Zepbound)
• Dulaglutide (the active ingredient in Trulicity)
• Liraglutide (the active ingredient in Saxenda)

The four-medication selection exceeds most competitors, which typically offer only semaglutide and tirzepatide. Compounded medications are prepared by NABP-accredited pharmacies using FDA-registered manufacturers. They contain the same active ingredients as brand-name drugs but are not FDA-approved products. For more on what compounding means, see our compound semaglutide with B12 guide.

With insurance coverage, Zealthy can prescribe brand-name Ozempic, Wegovy, Mounjaro, and Zepbound. The platform's insurance coordination team handles prior authorizations and benefit verification.

This is Zealthy's strongest differentiator. Getting brand-name GLP-1 medications covered by insurance is notoriously difficult. Prior authorizations are frequently denied, and the appeals process can take weeks. Zealthy claims to streamline this process.

If your insurance covers brand-name GLP-1 drugs, the potential savings are significant: $25 per month copay versus $286+ per month for compounded alternatives. However, insurance approval is not guaranteed, and the process can take several weeks. For information on insurance coverage, see our tirzepatide cost with insurance guide.

LegitScript: Certified. Zealthy holds current LegitScript certification, which requires compliance with healthcare regulations and proper pharmacy licensing.

Pharmacy partners are accredited. Zealthy uses NABP-accredited pharmacies with FDA-registered manufacturers for compounded medications.

Apple App Store: 4.2/5 across 2,779 ratings. The app rating is respectable and suggests a functional product experience for most users.

Real weight loss results. Patients who receive and consistently use the medication report significant weight loss. Clinical trials show GLP-1 receptor agonists produce 15 to 20% body weight reduction over 68 weeks (Jastreboff et al., N Engl J Med, 2022). Zealthy claims similar results among active patients, consistent with this published trial data.

Insurance coordination. Multiple users praise the platform's ability to navigate insurance paperwork and secure brand-name GLP-1 coverage. This service is genuinely useful and rare among competitors.

Active DOJ/FTC lawsuit (June 2024, pending). The Department of Justice filed suit against Zealthy for violating the Restore Online Shoppers' Confidence Act (ROSCA). The complaint alleges: failure to clearly disclose subscription terms before charging, failure to get informed consent for negative-option billing, and failure to provide simple cancellation mechanisms. The case is pending with no settlement as of March 2026.

FitRx LLC FDA warning letter (February 2026). The FDA issued a warning letter to FitRx LLC, the entity that operates Zealthy, for distributing misbranded drugs. This is a separate regulatory action from the DOJ lawsuit. FitRx LLC is the current operating name behind the Zealthy brand, making this warning directly relevant to current patients.

Founder background. Kyle Robertson founded Cerebral, which reached a $4.8 billion valuation before settling with the FTC for $7 million over deceptive business practices and facing DEA investigations for overprescribing controlled substances. Robertson left Cerebral in 2022 and launched Zealthy the same year. The DOJ complaint names him personally.

BBB: Not rated, "Pattern of Complaints" alert. The Better Business Bureau has not rated Zealthy but has flagged a pattern of complaints related to billing practices. The company is not BBB-accredited.

Trustpilot: 3.2/5 on getzealthy.com (~5,900 reviews). The rating is categorized as "Average," with a stark split: 50% five-star and 40% one-star reviews. A separate Trustpilot profile at zealthy.com shows 2.1/5 ("Poor"). Some third-party sites cite a 4.7 rating, but the actual Trustpilot page shows 3.2 as of March 2026.

Billing complaints. Customers report unauthorized charges up to $1,124, charges under the alternate name "ZFit," continued billing after cancellation, and difficulty obtaining refunds. These complaints are the dominant theme across Trustpilot, ConsumerAffairs, and Reddit.

State coverage claims. Zealthy advertises availability in 50 states but operates in approximately 34 states. The discrepancy has not been publicly addressed.

Corporate entity maze. The company has operated under multiple names: Zealthy Inc., Gronk Inc., FitRx LLC, AM Rx, and RoenRX. Each name change adds a layer of opacity for patients trying to verify the company or dispute charges.

• Competitive pricing for compounded GLP-1 medications
• Insurance coordination team that handles prior authorizations
• Fast signup process with quick initial consultations
• Unlimited provider messaging for dosage questions
• Real weight loss results (15 to 55+ pounds reported)
• Both compounded and brand-name medication options
• Wider medication selection than most competitors (4 GLP-1 compounds)

The patients who have positive experiences tend to be those who successfully receive their medication on time and interact primarily through the app. When Zealthy's service works as intended, the pricing and medication access are genuinely competitive.

• Continued billing after cancellation (the single most frequent complaint)
• Charges under alternate names ("ZFit") causing bank statement confusion
• Customer service unresponsive or giving conflicting information
• Shipping delays: some patients waited a month or more for medication
• Membership fee not clearly disclosed as separate from medication cost
• App glitches, login issues, portal errors
• Difficulty obtaining refunds for unauthorized charges
• Double charges on credit cards

The complaints cluster heavily around billing and cancellation, which aligns with the DOJ complaint's allegations.

Dated reviews sharpen the picture of current operations.

One Trustpilot reviewer in February 2026 reported $1,124 in unauthorized charges after attempting to cancel. The reviewer described multiple calls and emails over two months with no resolution and ultimately filed a chargeback through their bank.

A December 2025 Reddit post documented a cancellation attempt that spanned three months. The poster reported continued billing through February 2026 despite written confirmation of cancellation, with customer support alternating between promises to "escalate" and silence.

A January 2026 ConsumerAffairs complaint described signing up for a $49 introductory membership, then receiving a $584 charge the following month for medication that had not been discussed during the consultation. The reviewer noted the charge appeared under "ZFit" rather than Zealthy.

For patients experiencing side effects from their GLP-1 medication, see our guides on semaglutide nausea, tirzepatide constipation, and tirzepatide headaches. For safety information on compounded formulations, see our compound tirzepatide safety guide.